Moving beyond first-line treatment options for OCD
OCD is characterized by obsessions and compulsions that cause distress, are time-consuming, and interfere with a patient's social, occupational, or other areas of functioning. SSRIs are first-line pharmacologic treatment options and produce response rates of up to 60% in patients with OCD. Seve...
Saved in:
Main Author: | Chris Paxos, PharmD, BCGP, BCPS, BCPP (Author) |
---|---|
Format: | Book |
Published: |
American Association of Psychiatric Pharmacists,
2022-11-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Impact of a pharmacist-driven tardive dyskinesia screening service
by: Niyati Butala, PharmD, BCPP, et al.
Published: (2021) -
Severe olanzapine-induced liver function test elevation
by: Ericka Crouse, PharmD, BCPP, BCGP, FASHP, FASCP, et al.
Published: (2023) -
An innovative approach to teaching depression and anxiety medication management: Virtual choose your own adventure, psychiatry edition
by: Nina Vadiei, PharmD, BCPP, et al.
Published: (2023) -
Safety of ECT in patients receiving an oral anticoagulant
by: Nicolette R. Centanni, PharmD, BCPS, BCGP, BCPP, et al.
Published: (2021) -
The Effect of Dipeptidyl Peptidase-4 Inhibitors on Macrovascular and Microvascular Complications of Diabetes Mellitus: A Systematic Review
by: Olesya M. Taylor, PharmD, BCPS, et al.
Published: (2020)